Hepatitis C in US Prisons: Prevalence & Barriers to Screening and Treating


Anne C. Spaulding, MD, MPH

Associate Professor, Department of Epidemiology, Emory University Rollins School of Public Health

Learning Objectives:

1. To be able to describe the portion of the US Hepatitis C epidemic borne by persons who go in and out of jails and prisons over the course of a year.
2. To explain why elimination of Hepatitis C in the US depends on treating correctional populations.
3. To describe the challenges prisons face in financing Hepatitis C cure for persons who are incarcerated.

A live webcast sponsored by:

Merck (Grant No. AAN170209041806), The N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667) and Clinical Directors Network, Inc. (CDN)


Thursday, January 25, 2018 from 12:30 PM to 2:00 PM EST

This activity is approved for up to 1.5 Prescribed credit(s) by the American Academy of Family Physicians (AAFP). Enduring CME Credits valid until January 25, 2019.

Recent Webcasts